Are there new relevant therapeutic endpoints in the modern era of the BCR::ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia?Hagop Kantarjian,Susan Branford,Massimo Breccia,Jorge Cortes,Fadi G. Haddad,Andreas Hochhaus,Timothy Hughes,Ghayas C. Issa,Elias Jabbour,Franck E. Nicolini,Koji Sasaki, Francois Xavier-MahonLeukemia(2024)引用 0|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要